Logo Image
News
Media
Between the LinesExpert InterviewsK-CastMedical World NewsPodcastsPopulation Health PerspectivesShorts
Conferences
Partners
More
Publications
All PublicationsMHE PublicationFormulary Watch SupplementsFormulary Watch SpotlightsSupplements And Featured Publications
Events
HSE SummitWebinars
CME/CE
Resources
PBMI InnovatorsEmerging LeadersInteractive ToolsSponsored Content
PBM Directory
Commentaries

Subscribe

  • News
  • Media
  • Conferences
  • Partners
  • Publications
  • Events
  • CME/CE
  • Resources
  • PBM Directory
  • Commentaries
  • Subscribe
  • ADHD
  • Acute Pain
  • Asthma
  • Atrial Fibrillation
  • Autoimmune Diseases
  • Biologics
  • Biosimilars
  • Blood Cancer
  • Breast Cancer
  • COVID-19
  • Cardiovascular Diseases
  • Depression
  • Dermatology
  • Digital Health
  • Drug Coverage
  • Duchenne Muscular Dystrophy
  • Eyecare
  • FDA
  • Friedreich Ataxia
  • Gene Therapy
  • Graft Versus Host Disease
  • HIV
  • Health Systems
  • Heart Failure
  • Hemophilia
  • Hypertrophic Cardiomyopathy (HCM)
  • Infectious Disease
  • Leukemia and Lymphoma
  • Liver Disease
  • Lung Cancer
  • Mental Health
  • Metabolic Dysfunction-Associated Steatohepatitis
  • Multiple Sclerosis
  • NSCLC
  • Neonatal Care
  • Nephrology
  • Obstetrics-Gynecology & Women's Health
  • Oncology
  • Oncology Biomarkers
  • Opioids
  • PTSD
  • Pediatrics
  • Plaque Psoriasis
  • Population Health
  • Post-Acute Care
  • Prescription Digital Therapeutics
  • Pulmonary Arterial Hypertension
  • RSV
  • Reproductive Health
  • Respiratory Conditions
  • Safety & Recalls
  • Schizophrenia
  • Shingles
  • Skin Cancer
  • Sleep Disorders
  • Solid Tumors
  • Spinal Muscular Atrophy
  • Substance Use Disorder
  • The Improving Patient Access Podcast
  • Type 2 Diabetes
  • Type I Diabetes
  • Type II Inflammation
  • Ulcerative Colitis
  • Uro-Oncology
  • Urothelial Carcinoma
  • Vaccines
  • Women's Health
  • Year in Review- Dermatology
Spotlight -
ASRS 2026|
Our July 2026 issue|
2026 State of Pharmacy survey results available now|
Free Webinar: The Great 340B Debate
Advertisement

Dan O'Brien

Advertisement

Articles by Dan O'Brien

Five things to know about the role of GPOs in the healthcare supply chain

ByJon Leibowitz,Dan O'Brien,Russell Anello
September 14th 2017

Here are 5 things to know about GPOs, their business model and role in the supply chain, and their impact on healthcare costs and competition

Advertisement

Latest Updated Articles

  • Five things to know about the role of GPOs in the healthcare supply chain
    Five things to know about the role of GPOs in the healthcare supply chain

    September 14th 2017



Advertisement
Advertisement

Trending on Managed Healthcare Executive

1

1,700 sites closed, 77,000 fewer children received PEPFAR-supported treatment after PEPFAR disruption | IAS 2026

2

Is 340B good for the healthcare system? Takeaways from an MHE/Drug Topics webinar

3

Payers lean on step therapy, formulary exclusions as IRA reshapes Part D benefit design

4

Antipsychotics are effective but can also lead to weight gain, impacting treatment adherence

5

Health Begins at Home: Why Housing Has Become a Strategic Priority for Managed Care

  • About Us
  • Advertise
  • Editorial
  • Contact Us
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Personal Information
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

  • Formulary Watch
  • Pharmacy Benefit Management Institute
Managed Healthcare Executive
Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us